Synthesis, Biological Evaluation and Molecular Modeling Studies of Propargyl-Containing 2,4,6-Trisubstituted Pyrimidine Derivatives as Potential Anti-Parkinson Agents (original) (raw)
Optimization of pyrrolo[3,4‐ f ]indole‐5,7‐dione and indole‐5,6‐dicarbonitrile derivatives as inhibitors of monoamine oxidase
Zhanna Chirkova
Drug Development Research, 2019
View PDFchevron_right
An investigation of the monoamine oxidase inhibition properties of pyrrolo[3,4-f ]indole-5,7-dione and indole-5,6-dicarbonitrile derivatives
Zhanna Chirkova
Drug Development Research, 2018
View PDFchevron_right
Synthesis and in vitro evaluation of pteridine analogues as monoamine oxidase B and nitric oxide synthase inhibitors
Louis Prins
Bioorganic & Medicinal Chemistry, 2009
View PDFchevron_right
Inhibition of Monoamine Oxidase-B by Condensed Pyridazines and Pyrimidines: Effects of Lipophilicity and Structure−Activity Relationships
C. Altomare
Journal of Medicinal Chemistry, 1998
View PDFchevron_right
Novel sulfanylphthalimide analogues as highly potent inhibitors of monoamine oxidase B
Anél Petzer
Bioorganic & Medicinal Chemistry Letters, 2012
View PDFchevron_right
New Pyrrole Inhibitors of Monoamine Oxidase: Synthesis, Biological Evaluation, and Structural Determinants of MAO-A and MAO-B Selectivity
Romano Silvestri
Journal of Medicinal Chemistry, 2007
View PDFchevron_right
Novel Arylalkenylpropargylamines as Neuroprotective, Potent, and Selective Monoamine Oxidase B Inhibitors for the Treatment of Parkinson’s Disease
Han Kiat Ho
Journal of Medicinal Chemistry, 2015
View PDFchevron_right
Synthesis, Biological Evaluation and 3D-QSAR of 1,3,5-Trisubstituted-4,5- Dihydro-(1H)-Pyrazole Derivatives as Potent and Highly Selective Monoamine Oxidase A Inhibitors
Arianna Granese
Current Medicinal Chemistry, 2006
View PDFchevron_right
Rational approaches towards reversible inhibition of type B monoamine oxidase. Design and evaluation of a novel 5H-Indeno[1,2-c]pyridazin-5-one derivative
Raphaël Frédérick
Bioorganic & Medicinal Chemistry Letters, 2003
View PDFchevron_right
Evaluation of the oxidation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) to toxic pyridinium cations by monoamine oxidase (MAO) enzymes and its use to search for new MAO inhibitors and protective agents
Tomás Herraiz
Journal of Enzyme Inhibition and Medicinal Chemistry, 2012
View PDFchevron_right
NOVEL MAO INHIBITORS FOR PARKINSON’S
Vinay Singh
View PDFchevron_right
Discovery of two new classes of potent monoamine oxidase-B inhibitors by tricky chemistry
Alexandra Gaspar, Lígia Gomes
Chem. Commun., 2015
View PDFchevron_right
Monoamine oxidase inhibition by selected anilide derivatives
Anél Petzer, Lesetja Legoabe
European Journal of Medicinal Chemistry, 2011
View PDFchevron_right
Chemical and Biological Evaluation of Novel 1H-Chromeno[3,2-c]pyridine Derivatives as MAO Inhibitors Endowed with Potential Anticancer Activity
Cosimo Altomare
International Journal of Molecular Sciences
View PDFchevron_right
Monoamine oxidase inhibitory activity of 3,5-biaryl-4,5-dihydro-1H-pyrazole-1- carboxylate derivatives
Surender Singh, G Ucar
View PDFchevron_right
The synthesis and evaluation of 8–benzyloxycaffeine analogues as inhibitors of monoamine oxidase B
Belinda Strydom
2009
View PDFchevron_right
Pyrazoline carboxylates as selective MAO-B inhibitors: Synthesis and Biological screening
Abhimanyu Dev
JOURNAL OF PHARMACEUTICAL CHEMISTRY, 2015
View PDFchevron_right
Synthesis and evaluation of β-carboline derivatives as potential monoamine oxidase inhibitors
Raphaël Frédérick
Bioorganic & Medicinal Chemistry, 2011
View PDFchevron_right
Synthetic and Natural Monoamine Oxidase Inhibitors as Potential Lead Compounds for Effective Therapeutics
Pradeep Kumar Singour
Central Nervous System Agents in Medicinal Chemistry, 2016
View PDFchevron_right
Discovery and Optimization of Pyrazoline Derivatives As Promising Monoamine Oxidase Inhibitors
Simone Carradori
Current Topics in Medicinal Chemistry, 2012
View PDFchevron_right
An evaluation of synthetic indole derivatives as inhibitors of monoamine oxidase
Zhanna Chirkova
Bioorganic & medicinal chemistry letters, 2016
View PDFchevron_right
Towards development of selective and reversible pyrazoline based MAO-inhibitors: Synthesis, biological evaluation and docking studies
Gülberk Uçar
Bioorganic & Medicinal Chemistry Letters, 2010
View PDFchevron_right
Synthesis and Evaluation of a Set of Para-Substituted 4-Phenylpiperidines and 4-Phenylpiperazines as Monoamine Oxidase (MAO) Inhibitors
Clas Sonesson, Susanna Waters
Journal of Medicinal Chemistry, 2012
View PDFchevron_right
Relevance of benzyloxy group in 2-indolyl methylamines in the selective MAO-B inhibition
M. Unzeta
British Journal of Pharmacology, 1999
View PDFchevron_right
M30, a novel multifunctional neuroprotective drug with potent iron chelating and brain selective monoamine oxidase-ab inhibitory activity for Parkinson’s disease
Shunit Gal-ben-ari
Parkinson’s Disease and Related Disorders, 2006
View PDFchevron_right
Evaluation of selective human MAO inhibitory activities of some novel pyrazoline derivatives
umut gökşen
Journal of Neural Transmission, 2013
View PDFchevron_right
Novel 1-(2-pyrimidin-2-yl)piperazine derivatives as selective monoamine oxidase (MAO)-A inhibitors
Betül Kaya
Journal of Enzyme Inhibition and Medicinal Chemistry, 2017
View PDFchevron_right
Monoamine Oxidase A and B Inhibitors of Some Synthesized Heterocyclic Derivatives and Their Structure Activity Relationships
Mohamed Abdulla
2013
View PDFchevron_right
Propargylamine as functional moiety in the design of multifunctional drugs for neurodegenerative disorders: MAO inhibition and beyond
Sarel Malan
Future Medicinal Chemistry, 2015
View PDFchevron_right
Inhibition of monoamine oxidase by indole-5,6-dicarbonitrile derivatives
Zhanna Chirkova
Bioorganic & Medicinal Chemistry Letters, 2015
View PDFchevron_right
Novel Series of Dual NRF2 Inducers and Selective MAO-B Inhibitors for the Treatment of Parkinson’s Disease
pablo Duarte
Antioxidants, 2022
View PDFchevron_right